On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Diversity in Clinical Trials Summit Underscores Need for Targeting More Broadly Representative Patient Populations

The Diversity in Clinical Trials Summit presented by Dynamic Global Events (“DGE”) in June is an unequaled venue for your team to establish strategies ensuring that a diversity of patient populations are represented in the testing of new drug products. 

A key element of conducting sound trials is ensuring that minority populations are included in the testing because they will comprise a portion of the affected patient profile, and may have unique responses to the trials.  But historically, clinical trials have excluded and overlooked them.   

The Diversity in Clinical Trials Summit aims to re-center drug development around patient diversity in order to improve health outcomes through equitable approaches

Key takeaways: 

  • Develop long-term relationships of trust with external partners 
  • Learn how decentralized testing can improve diverse representation in clinical trials
  • Gain greater awareness of the importance of diversity, equity and inclusion across the biopharma industry
  • Learn to build better patient outcomes through collaborative networks in clinical testing
  • Understand the impact of the Clinical Treatment Act on representative patient populations

Education and Opportunity:

DGE is a life science leader experienced in organizing B2B events with a focus on the informational and networking needs of professionals within health-related industries such as pharmaceutical, biotechnology, medical devices and the healthcare treatment sector.

For more information about this event, please visit https://nnw.fm/vzn8H

About NetworkNewsWire

NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 50+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

Archives

Select A Month

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217